Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ProPhase Labs (PRPH) EBIT: 2009-2024

Historic EBIT for ProPhase Labs (PRPH) over the last 16 years, with Dec 2024 value amounting to -$38.6 million.

  • ProPhase Labs' EBIT rose 26.48% to -$4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$29.6 million, marking a year-over-year increase of 8.32%. This contributed to the annual value of -$38.6 million for FY2024, which is 82.04% down from last year.
  • ProPhase Labs' EBIT amounted to -$38.6 million in FY2024, which was down 82.04% from -$21.2 million recorded in FY2023.
  • ProPhase Labs' EBIT's 5-year high stood at $23.6 million during FY2022, with a 5-year trough of -$38.6 million in FY2024.
  • For the 3-year period, ProPhase Labs' EBIT averaged around -$12.1 million, with its median value being -$21.2 million (2023).
  • Per our database at Business Quant, ProPhase Labs' EBIT skyrocketed by 570.98% in 2021 and then slumped by 189.93% in 2023.
  • ProPhase Labs' EBIT (Yearly) stood at -$2.1 million in 2020, then skyrocketed by 570.98% to $9.8 million in 2021, then spiked by 140.74% to $23.6 million in 2022, then crashed by 189.93% to -$21.2 million in 2023, then plummeted by 82.04% to -$38.6 million in 2024.